Fig. 3From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancerThe association of NNMT expression with OS. a NNMT was associated with a shorter OS (HR: 2.28, 95%CI: 1.51–3.43, Log-rank P < 0.001) in GSE9891 dataset; b NNMT was associated with a reduced OS (HR: 1.55, 95%CI: 1.02–2.36, Log-rank P = 0.039) in TCGA datasetBack to article page